Insider Transactions in Q1 2024 at Gain Therapeutics, Inc. (GANX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Jeffrey Scott Riley Director |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$90,000
$3.86 P/Share
|
|
Mar 26
2024
|
Matthias Alder Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,085
-22.35%
|
$24,340
$4.06 P/Share
|
|
Mar 26
2024
|
Matthias Alder Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,212
+15.81%
|
-
|